Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 7 | 2020 | 195 | 0.620 |
Why?
|
| Estrogen Receptor alpha | 3 | 2012 | 8 | 0.530 |
Why?
|
| Epithelial Cells | 4 | 2018 | 36 | 0.490 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2012 | 17 | 0.480 |
Why?
|
| Cell Proliferation | 8 | 2020 | 90 | 0.420 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2020 | 42 | 0.360 |
Why?
|
| Cell Line, Tumor | 11 | 2020 | 128 | 0.350 |
Why?
|
| Lithium | 4 | 2004 | 11 | 0.340 |
Why?
|
| Magnesium | 4 | 2004 | 34 | 0.300 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 99 | 0.280 |
Why?
|
| Tamoxifen | 1 | 2007 | 17 | 0.270 |
Why?
|
| MAP Kinase Signaling System | 3 | 2019 | 22 | 0.260 |
Why?
|
| Breast | 1 | 2006 | 9 | 0.240 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2018 | 15 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2017 | 21 | 0.220 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 125 | 0.220 |
Why?
|
| Mutation | 2 | 2018 | 175 | 0.200 |
Why?
|
| Humans | 18 | 2020 | 12240 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2020 | 60 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2013 | 23 | 0.170 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2018 | 9 | 0.160 |
Why?
|
| STAT6 Transcription Factor | 1 | 2020 | 3 | 0.160 |
Why?
|
| Trastuzumab | 1 | 2020 | 16 | 0.160 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 11 | 0.160 |
Why?
|
| Receptor, ErbB-2 | 1 | 2020 | 32 | 0.160 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2020 | 13 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2020 | 69 | 0.150 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2019 | 3 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 29 | 0.150 |
Why?
|
| Ion Channels | 1 | 2020 | 130 | 0.150 |
Why?
|
| Macrophages | 1 | 2018 | 38 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 47 | 0.130 |
Why?
|
| Female | 9 | 2020 | 6974 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 23 | 0.130 |
Why?
|
| Animals | 7 | 2020 | 2092 | 0.130 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 39 | 0.120 |
Why?
|
| Bipolar Disorder | 4 | 2004 | 47 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 151 | 0.120 |
Why?
|
| Mice | 5 | 2020 | 760 | 0.110 |
Why?
|
| Phosphorylation | 3 | 2013 | 78 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2019 | 246 | 0.100 |
Why?
|
| Erythrocytes | 2 | 2003 | 13 | 0.100 |
Why?
|
| Ion Transport | 2 | 2003 | 21 | 0.100 |
Why?
|
| ras Proteins | 1 | 2013 | 7 | 0.100 |
Why?
|
| Precancerous Conditions | 2 | 2018 | 11 | 0.090 |
Why?
|
| Receptors, Androgen | 1 | 2012 | 4 | 0.090 |
Why?
|
| Middle Aged | 4 | 2019 | 4043 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 26 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2004 | 9 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 2 | 2007 | 54 | 0.070 |
Why?
|
| Oncogenes | 1 | 2009 | 9 | 0.070 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2007 | 1 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 30 | 0.070 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2007 | 3 | 0.070 |
Why?
|
| Up-Regulation | 3 | 2017 | 89 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2007 | 15 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2007 | 7 | 0.070 |
Why?
|
| Heterografts | 2 | 2020 | 12 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2007 | 93 | 0.060 |
Why?
|
| Neuroblastoma | 2 | 2003 | 11 | 0.060 |
Why?
|
| Intracellular Fluid | 2 | 2003 | 3 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 69 | 0.060 |
Why?
|
| Second Messenger Systems | 1 | 2006 | 4 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2006 | 23 | 0.060 |
Why?
|
| Response Elements | 1 | 2006 | 5 | 0.060 |
Why?
|
| Estrogens | 1 | 2006 | 10 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2006 | 33 | 0.060 |
Why?
|
| Mice, Nude | 3 | 2013 | 17 | 0.060 |
Why?
|
| Estradiol | 1 | 2006 | 26 | 0.060 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 101 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2019 | 7 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2020 | 45 | 0.060 |
Why?
|
| Gene Targeting | 2 | 2019 | 5 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2019 | 35 | 0.050 |
Why?
|
| Transducin | 1 | 2004 | 1 | 0.050 |
Why?
|
| Guanosine Diphosphate | 1 | 2004 | 2 | 0.050 |
Why?
|
| Time Factors | 1 | 2006 | 695 | 0.050 |
Why?
|
| Glycine | 1 | 2003 | 5 | 0.050 |
Why?
|
| Chlorides | 1 | 2003 | 17 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2007 | 1478 | 0.050 |
Why?
|
| Cobalt | 1 | 2003 | 46 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2003 | 125 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 179 | 0.050 |
Why?
|
| Models, Biological | 1 | 2003 | 191 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 2 | 2013 | 5 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2013 | 3 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 16 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 2 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 6 | 0.040 |
Why?
|
| Cell Survival | 1 | 2020 | 46 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2020 | 21 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 6 | 0.040 |
Why?
|
| NADPH Oxidases | 1 | 2020 | 24 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 42 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 171 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 53 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 168 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 3 | 0.040 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 6 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 16 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 24 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2018 | 11 | 0.030 |
Why?
|
| Pancreas | 1 | 2018 | 16 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2009 | 10 | 0.030 |
Why?
|
| RNA Interference | 2 | 2007 | 19 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 338 | 0.030 |
Why?
|
| Pre-B-Cell Leukemia Transcription Factor 1 | 1 | 2017 | 1 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2017 | 157 | 0.030 |
Why?
|
| Binding, Competitive | 2 | 2004 | 14 | 0.030 |
Why?
|
| Adult | 2 | 2017 | 3557 | 0.030 |
Why?
|
| Biological Transport | 2 | 2003 | 23 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 1 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2013 | 1 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 4 | 0.020 |
Why?
|
| Point Mutation | 1 | 2013 | 19 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 25 | 0.020 |
Why?
|
| Metribolone | 1 | 2012 | 1 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2012 | 2 | 0.020 |
Why?
|
| Tosyl Compounds | 1 | 2012 | 2 | 0.020 |
Why?
|
| Anilides | 1 | 2012 | 3 | 0.020 |
Why?
|
| Androgen Antagonists | 1 | 2012 | 3 | 0.020 |
Why?
|
| Nitriles | 1 | 2012 | 5 | 0.020 |
Why?
|
| Androgens | 1 | 2012 | 5 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 64 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 90 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 97 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2009 | 6 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 7 | 0.020 |
Why?
|
| Mammary Glands, Human | 1 | 2009 | 5 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 6 | 0.020 |
Why?
|
| Aged | 1 | 2017 | 4000 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2009 | 48 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2007 | 1 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2007 | 2 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2007 | 3 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2007 | 3 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2007 | 5 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2007 | 5 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2007 | 22 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2007 | 17 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2007 | 46 | 0.020 |
Why?
|
| Alleles | 1 | 2007 | 119 | 0.020 |
Why?
|
| Prognosis | 1 | 2007 | 363 | 0.020 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2006 | 2 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2006 | 5 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2006 | 5 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 33 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 68 | 0.010 |
Why?
|
| Rod Cell Outer Segment | 1 | 2004 | 1 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2004 | 2 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2004 | 5 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2004 | 39 | 0.010 |
Why?
|
| Cattle | 1 | 2004 | 54 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2004 | 117 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 110 | 0.010 |
Why?
|
| Phospholipids | 1 | 2003 | 6 | 0.010 |
Why?
|
| Sodium | 1 | 2003 | 33 | 0.010 |
Why?
|
| Isotopes | 1 | 2003 | 3 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 6 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 63 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 24 | 0.010 |
Why?
|
| Thermodynamics | 1 | 2003 | 29 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 81 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 275 | 0.010 |
Why?
|
| Male | 1 | 2003 | 6815 | 0.010 |
Why?
|